Similarly, SNX4 was decreased with AAV-NF-α1/CPE and AAV-NF-α1/CPE-E342Q treatment in 3xTg-AD mice compared to 3xTg+GFP mice (Fig 5C). Here, SNX4 is linked to Alzheimer disease.